In a recent study of type 2 diabetes patients, Zhang et al found that polymorphisms in IRS1 were associated with higher platelet activity and suboptimal responses to drugs such as clopidogrel (Plavix), which is used to prevent platelet adhesion in patients at risk of stroke [28]. The gene discussed is IRS1; the disease is type 2 diabetes mellitus.